Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin–resistant Enterococcus spp (VRE): a single-center university hospital experience
- 1 January 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 51 (1) , 57-61
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: a short case seriesBMC Urology, 2013
- Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional studyAntimicrobial Resistance & Infection Control, 2012
- The rise of the Enterococcus: beyond vancomycin resistanceNature Reviews Microbiology, 2012
- Emergence of Daptomycin-Resistant VRE: Experience of a Single InstitutionInfection Control & Hospital Epidemiology, 2011
- Vancomycin‐Resistant Enterococcal Urinary Tract InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infectionsInternational Journal of Antimicrobial Agents, 2009
- Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococciClinical Microbiology and Infection, 2008
- Determination of Risk Factors Associated With Isolation of Linezolid-Resistant Strains of Vancomycin-Resistant EnterococcusInfection Control & Hospital Epidemiology, 2007
- Absence of bioactive metabolites of amplcillin and amoxycillin in manJournal of Antimicrobial Chemotherapy, 1978
- SODIUM AMPICILLINThe American Journal of the Medical Sciences, 1965